|
Pharmacopeia,
Eos boards cancel merger plans
PHARMACOPEIA Corp said that the company’s acquisition agreement
with Eos Biotechnology Inc had been cancelled by the boards of both
firms,
Elan,
AHP suspend Alzheimer’s vaccine studies
IRISH drug firm Elan Corp Plc and partner American Home Products
Corp (AHP)
FDA
panel rejects BMS pravastatin/aspirin combo
A US Food and Drug Administration (FDA) advisory committee voted
7-1, with one abstention,
At
a Glance
Schering-Plough
may start waiting list for hepatitis drug
DUE to insufficient supply, drug company Schering-Plough Corp.
announced that it may start a waiting list for patients who need
its hepatitis C drug PEG-Intron.
US
trial to study mifepristone for cancer
PATIENTS are being enrolled in the first clinical trial to study
whether mifeprist one, the abortion pill also known as RU-486, may
treat certain types of endometrial cancer, researchers said.
Viagra
may be subsidised in Australia
VIAGRA use may be subsidised by Australian taxpayers if a recommendation
by the Pharmaceutical Benefits Advisory Committee (PBAC) is approved
by Cabinet.
|
